Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

Healthy Extracts (HYEX) EBIAT (2016 - 2025)

Healthy Extracts filings provide 11 years of EBIAT readings, the most recent being -$153986.0 for Q4 2025.

  • On a quarterly basis, EBIAT rose 65.55% to -$153986.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$881120.0, a 4.87% decrease, with the full-year FY2025 number at -$881119.0, down 4.81% from a year prior.
  • EBIAT hit -$153986.0 in Q4 2025 for Healthy Extracts, up from -$395394.0 in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $536735.0 in Q4 2021 to a low of -$1.3 million in Q1 2021.
  • Median EBIAT over the past 5 years was -$387004.5 (2023), compared with a mean of -$358225.8.
  • Biggest five-year swings in EBIAT: plummeted 19334.71% in 2023 and later soared 242.97% in 2024.
  • Healthy Extracts' EBIAT stood at $536735.0 in 2021, then tumbled by 91.91% to $43417.0 in 2022, then plummeted by 972.04% to -$378615.0 in 2023, then dropped by 18.04% to -$446929.0 in 2024, then skyrocketed by 65.55% to -$153986.0 in 2025.
  • The last three reported values for EBIAT were -$153986.0 (Q4 2025), -$395394.0 (Q3 2025), and $67120.0 (Q2 2025) per Business Quant data.